Encompass Health Corporation (NYSE:EHC) to Issue $0.19 Quarterly Dividend

Key Points

• Encompass Health Corporation announced a quarterly dividend of $0.19 per share, payable on January 15th, with a dividend yield of 0.6%.
• The company reported earnings of $0.93 per share for the last quarter, with expectations to earn $5.28 per share next year, resulting in a future payout ratio of 12.9%.
• Encompass Health's stock reached $126.51, experiencing a trading volume of 593,398 shares compared to an average of 775,434 shares.

Encompass Health Corporation (NYSE:EHC - Get Free Report) declared a quarterly dividend on Thursday, October 23rd. Shareholders of record on Friday, January 2nd will be paid a dividend of 0.19 per share on Thursday, January 15th. This represents a c) dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Friday, January 2nd.

Encompass Health has a dividend payout ratio of 12.2% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Encompass Health to earn $5.28 per share next year, which means the company should continue to be able to cover its $0.68 annual dividend with an expected future payout ratio of 12.9%.

Encompass Health Stock Performance

NYSE:EHC traded up $0.23 during trading hours on Thursday, reaching $126.51. The company had a trading volume of 593,398 shares, compared to its average volume of 775,434. Encompass Health has a 1-year low of $87.85 and a 1-year high of $127.86. The firm has a market cap of $12.74 billion, a PE ratio of 24.76, a price-to-earnings-growth ratio of 2.18 and a beta of 0.93. The business's 50 day moving average price is $123.98 and its 200-day moving average price is $117.66. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.06 and a quick ratio of 1.06.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings results on Wednesday, March 16th. The company reported $0.93 earnings per share (EPS) for the quarter. Encompass Health had a return on equity of 17.83% and a net margin of 9.22%.The company had revenue of $136.30 million during the quarter. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. Research analysts forecast that Encompass Health will post 4.8 EPS for the current year.

Insider Buying and Selling

In other Encompass Health news, EVP Patrick William Tuer sold 1,020 shares of the company's stock in a transaction on Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total value of $126,061.80. Following the completion of the sale, the executive vice president directly owned 18,846 shares in the company, valued at $2,329,177.14. This represents a 5.13% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 2.00% of the company's stock.

Institutional Trading of Encompass Health

Large investors have recently added to or reduced their stakes in the stock. OneDigital Investment Advisors LLC purchased a new stake in shares of Encompass Health during the 1st quarter valued at approximately $263,000. GAMMA Investing LLC increased its stake in Encompass Health by 21.5% during the first quarter. GAMMA Investing LLC now owns 2,366 shares of the company's stock worth $240,000 after acquiring an additional 419 shares during the last quarter. Sequoia Financial Advisors LLC raised its position in Encompass Health by 6.7% in the first quarter. Sequoia Financial Advisors LLC now owns 2,727 shares of the company's stock valued at $276,000 after purchasing an additional 172 shares during the period. Cambridge Investment Research Advisors Inc. lifted its stake in shares of Encompass Health by 30.1% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 9,597 shares of the company's stock valued at $972,000 after purchasing an additional 2,218 shares during the last quarter. Finally, Intech Investment Management LLC grew its holdings in shares of Encompass Health by 21.8% during the 1st quarter. Intech Investment Management LLC now owns 21,329 shares of the company's stock worth $2,160,000 after purchasing an additional 3,815 shares during the period. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.